Indeed, CD95 is reported to activate nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) pathways, the activation of which may lead to inflammation, proliferation, differentiation, regeneration, angiogenesis, and even tumor progression [23,64,65,66,67,68,69,70,71]. This evidence concerns the gene FAS and neoplasm.